IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter

FASEB Journal

Volumn 27, Issue 12, 2013, Pages 4899-4908

  Ock, Sangmi ^a   Ahn, Jihyun ^a   Lee, Seok Hong ^a   Kang, Hyun ^b   Offermanns, Stefan ^c   Ahn, Hwa Young ^a   Jo, Young Suk ^d   Shong, Minho ^d   Cho, Bo Youn ^a   Jo, Daewoong ^e   Abel, E Dale ^f   Lee, Tae Jin ^a   Park, Woo Jin ^g,h   Lee, In Kyu ^b,i,j   Kim, Jaetaek ^a  

^a Chung Ang University   (South Korea)

^b Department of Anesthesiology ^*  (South Korea)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^d Chungnam National University College of Medicine   (South Korea)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g Research Laboratory   (South Korea)

^h Gwangju Institute of Science and Technology (GIST)   (South Korea)

ⁱ Pusan National University   (South Korea)

^j Kyungpook National University School of Medicine   (South Korea)

more..

Author keywords

Hypertrophy; MCT8; Proliferation; T4

Indexed keywords

ANTITHYROID AGENT; MONOCARBOXYLATE TRANSPORTER 8; SODIUM PERCHLORATE; SOMATOMEDIN C; THIAMAZOLE; THYROID HORMONE; THYROTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GOITER; HORMONE RELEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SUBCLINICAL HYPOTHYROIDISM; THYROID CELL; THYROID FUNCTION; THYROID HORMONE RELEASE; THYROXINE BLOOD LEVEL;

HYPERTROPHY; MCT8; PROLIFERATION; T4;

ANIMALS; ANTITHYROID AGENTS; DOWN-REGULATION; GOITER; MEMBRANE TRANSPORT PROTEINS; METHIMAZOLE; MICE; MICE, KNOCKOUT; PERCHLORATES; RECEPTOR, IGF TYPE 1; SODIUM COMPOUNDS; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 84890518350     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-231381     Document Type: Article

References (42)

1. Santisteban, P. (2012) Development of the hypothalamic-pituitary-thyroid axis. In Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text (Braverman, L. E., and Cooper, D., eds) pp. 4-23, Lippincott Williams & Wilkins, Philadelphia
2. Medeiros-Neto, G., Camargo, R. Y., and Tomimori, E. K. (2012) Approach to and treatment of goiters. Med. Clin. North Am. 96, 351-368
3. Graf, H. (2012) Multiple goiter. In Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text (Braverman, L. E., and Cooper, D., eds) pp. 635-649, Lippincott Williams & Wilkins, Philadelphia
4. Marians, R. C., Ng, L., Blair, H. C., Unger, P., Graves, P. N., and Davies, T. F. (2002) Defining thyrotropin-dependent and-independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc. Natl. Acad. Sci. U. S. A. 99, 15776-15781
5. Eggo, M. C., Bachrach, L. K., and Burrow, G. N. (1990) Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function. Growth Factors 2, 99-109
6. Takahashi, S., Conti, M., and Van Wyk, J. J. (1990) Thyrotropin potentiation of insulin-like growth factor-I dependent deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s). Endocrinology 126, 736-745
7. Kimura, T., Van Keymeulen, A., Golstein, J., Fusco, A., Dumont, J. E., and Roger, P. P. (2001) Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr. Rev. 22, 631-656
8. Clément, S., Refetoff, S., Robaye, B., Dumont, J. E., and Schurmans, S. (2001) Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-I receptor in the thyroid gland. Endocrinology 142, 5131-5139
9. Misaki, T., Maciel, R. M., Tramontano, D., Moses, A. C., Lombardi, A., and Ingbar, S. H. (1998) Supranormal stimulation of deoxyribonucleic acid synthesis in FRTL5 cells by serum from patients with untreated acromegaly. J. Clin. Endocrinol. Metab. 66, 1227-1232
10. Cheung, N. W., and Boyages, S. C. (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin. Endocrinol. 46, 545-549
11. Kasagi, K., Shimatsu, A., Miyamoto, S., Misaki, T., Sakahara, H., and Konishi, J. (1999) Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland. Thyroid 9, 791-796
12. Miyakawa, M., Saji, M., Tsushima, T., Wakai, K., and Shizume, K. (1988) Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J. Clin. Endocrinol. Metab. 67, 973-978
13. Völzke, H., Friedrich, N., Schipf,. S, Haring, R., Lüdemann, J., Nauck, M., Dörr, M., Brabant, G., and Wallaschofski, H. (2007) Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. J. Clin. Endocrinol. Metab. 92, 4039-4045
14. Dormitzer, P. R., Ellison, P. T., and Bode, H. H. (1989) Anomalously low endemic goiter prevalence among Efe pygmies. Am. J. Phys. Anthropol. 78, 527-531
15. Kim, J., Wende, A. R., Sena, S., Theobald, H. A., Soto, J., Sloan, C., Wayment, B. E., Litwin, S. E., Holzenberger, M., LeRoith, D., and Abel, E. D. (2008) Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol. Endocrinol. 22, 2531-2543
16. Kero, J., Ahmed, K., Wettschureck, N., Tunaru, S., Wintermantel, T., Greiner, E., Schütz, G., and Offermanns, S. (2007) Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development. J. Clin. Invest. 117, 2399-2407
17. Cadoret, A., Desbois-Mouthon, C., Wendum, D., Leneuve, P., Perret, C., Tronche, F., Housset, C., and Holzenberger, M. (2005) c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor. Int. J. Cancer 114, 668-672
18. Yeager, N., Klein-Szanto, A., Kimura, S., and Di Cristofano, A. (2007) Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Res. 67, 959-966
19. Ock, S., Lee, S. H., Ahn, J., Lee, T. J., Cho, C. H., Abel, E. D., Kimura, S., and Kim, J. (2011) Conditional deletion of insulin receptor in thyrocytes does not affect thyroid structure and function. Endocr. J. 58, 1013-1019
20. Di Cosmo, C., Lia, X. H., Dumitrescu, A. M., Philp, N. J., Weiss, R. E., and Refetoff, S. (2010) Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. J. Clin. Invest. 120, 3377-3388
21. Field, J. B., Larsen, P. R., Yamashita, K., Mashiter, K., and Dekker, A. (1973) Demonstration of iodide transport defect but normal iodide organification in nonfunctioning nodules of human thyroid glands. J. Clin. Invest. 52, 2404-2410
22. Smith, V. E., Read, M. L., Turnell, A. S., Sharma, N., Lewy, G. D., Fong, J. C., Seed, R. I., Kwan, P., Ryan, G., Mehanna, H., Chan, S. Y., Darras, V. M., Boelaert, K., Franklyn, J. A., and McCabe, C. J. (2012) PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. Endocrinology 153, 3526-3536
23. Lemoine, N. R., Mayall, E. S., Jones, T., Sheer, D., McDermid, S., Kendall-Taylor, P., and Wynford-Thomas, D. (1989) Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br. J. Cancer 60, 897-903
24. Maia, A. L., Goemann, I. M., Meyer, E. L., and Wajner, S. M. (2011) Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. J. Endocrinol. 209, 283-297
25. Bidey, S. P., Hill, D. J., and Eggo, M. C. (1999) Growth factors and goitrogenesis. J. Endocrinol. 160, 321-332
26. Ramsden, J. D., Buchanan, M. A., Egginton, S., Watkinson, J. C., Mautner, V., and Eggo, M. C. (2005) Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signaling. Endocrinology 146, 2895-2902
27. Brewer, C., Yeager, N., and Di Cristofano, A. (2007) Thyroidstimulating hormone initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT. Cancer Res. 67, 8002-8006
28. Belfiore, A., Pandini, G., Vella, V., Squatrito, S., and Vigneri, R. (1999) Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer. Biochimie (Paris) 81, 403-407
29. Frittitta, L., Sciacca, L., Catalfamo, R., Ippolito, A., Gangemi, P., Pezzino, V., Filetti, S., and Vigneri, R. (1999) Functional insulin receptors are overexpressed in thyroid tumors: is this an early event in thyroid tumorigenesis? Cancer 85, 492-498
30. Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J., Caunt, C. J., McArdle, C. A., Pavenstädt, H., Tavaré, J.M., Herzenberg, A. M., Kahn, C. R., Mathieson, P. W., Quaggin, S. E., Saleem, M. A., and Coward, R. J. (2010) Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 12, 329-340
31. Müller, K., Führer, D., Mittag, J., Klöting, N., Blüher, M., Weiss, R. E., Many, M. C., Schmid, K. W., and Krohn, K. (2011) TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia. Mol. Endocrinol. 25, 1867-1879
32. Missero, C., Cobellis, G., De Felice, M., and Di Lauro, R. (1998) Molecular events involved in differentiation of thyroid follicular cells. Mol. Cell. Endocrinol. 140, 37-43
33. Weiss, S. J., Philp, N. J., Ambesi-Impiombato, F. S., and Grollman, E. F. (1984) Thyrotropin-stimulated iodide transport mediated by adenosine 3=,5=-monophosphate and dependent on protein synthesis. Endocrinology 114, 1099-1107
34. Kogai, T., Endo, T., Saito, T., Miyazaki, A., Kawaguchi, A., and Onaya, T. (1997) Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138, 2227-2232
35. Dumitrescu, A. M., Liao, X. H., Weiss, R. E., Millen, K., and Refetoff, S. (2006) Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147, 4036-4043
36. Nishimura, M., and Naito, S. (2008) Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab. Pharmacokinet. 23, 22-44
37. Trajkovic, M., Visser, T. J., Mittag, J., Horn, S., Lukas, J., Darras, V. M., Raivich, G., Bauer, K., and Heuer, H. (2007) Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J. Clin. Invest. 117, 627-635
38. Liao, X. H., Di Cosmo, C., Dumitrescu, A. M., Hernandez, A., Van Sande, J., St Germain, D. L., Weiss, R. E., Galton, V. A., and Refetoff, S. (2011) Distinct roles of deiodinases on the phenotype of Mct8 defect: a comparison of eight different mouse genotypes. Endocrinology 152, 1180-1091
39. Derwahl, M., Broecker, M., and Kraiem, Z. (1999) Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J. Clin. Endocrinol. Metab. 84, 829-834
40. Tsui, S., Naik, V., Hoa, N., Hwang, C. J., Afifiyan, N. F., Sinha Hikim, A., Gianoukakis, A. G., Douglas, R. S., and Smith, T. J. (2008) Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J. Immunol. 181, 4397-4405
41. Cheung, N. W., Lou, J. C., and Boyages, S. C. (1996) Growth hormone does not increase thyroid size in the absence of thyrotropin: a study in adults with hypopituitarism. J. Clin. Endocrinol. Metab. 81, 1179-1183
42. Tode, B., Serio, M., Rotella, C. M., Galli, G., Franceschelli, F., Tanini, A., and Toccafondi, R. (1989) Insulin-like growth factor-I: autocrine secretion by human thyroid follicular cells in primary culture. J. Clin. Endocrinol. Metab. 69, 639-647